Shares of Teladoc Health are trading at their 52-week lows. The stock is down 48% in just six months while the S&P 500 has risen 7%. From afar, it looks like this may be a problematic investment and one that investors should be dumping. But, the business looks solid despite the recent sell-off.
Companies who exhibited their inventions at the 2022 tech convention CES are trying to fill that void. Their innovations are providing novel ways for patients to connect with healthcare providers while also gathering new sources of information about patient health.
COLORADO SPRINGS, Colo. (KRDO) - One unexpected aspect of the coronavirus pandemic is how it has driven a lot of innovation, including a vast expansion of virtual doctor visits. Two years later, that segment of healthcare is still a bit of a work in progress.
Telehealth companies struggling to stand out in a crowded virtual care market are increasingly leaning on chatbots, online questionnaires, and automated follow-ups to triage patients and trim costs, letting them care for more patients for less money.
Telehealth took off during the pandemic, but 2021 was a brutal awakening. The healthcare industry is still figuring out how it fits into the big picture.